Benitec Biopharma Inc. (BNTC) Form S-3 — Sep 14, 2026
Benitec Biopharma filed a new universal shelf registration statement on Form S-3 registering up to $200,000,000 of securities, spanning common stock, preferred stock, debt securities, warrants, and units, which may be offered from time to time in one or more takedowns as market conditions allow. This new shelf is separate from, and will be effective concurrently with, the company's September 2025 $200 million shelf (File No. 333-290455), under which Benitec raised approximately $104 million in a November 2025 underwritten offering and concurrent registered direct offering.
Key figures
- Prior Shelf File No
- 333-290455
- Shelf Capacity Usd
- 200000000
- Last Sale Price Date
- 2026-09-11
- Sec Registration Fee
- 27620
- Securities Registered
- common stock, preferred stock, debt securities, warrants, units
- Last Reported Sale Price
- 12.19
- Prior Shelf Capacity Usd
- 200000000
- Authorized Common Shares
- 160000000
- Authorized Preferred Shares
- 5000000
- November2025 Offering Proceeds
- approximately $104 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.